The properties of monoclonal and polyclonal Abs, convalescent plasma, and other Ig-based drugs are studied in many countries to assess the possibility of their use as active pharmacological drug substances for the prevention and treatment of influenza and other ARVI [69,73,74,75]. The gene discussed is DDX41; the disease is influenza.